Showing results (2481-2490 of 2,978) with videos related to
Sort By:
Pageof 298
European Journal of Cancer (Oxford, England : 1990)|April 15, 2022
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trialGeorg Martin Haag, Christoph Springfeld, Barbara Grün, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|January 29, 2015
Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: a recommendation from experienced users : A position statement on the use of bioresorbable vascular scaffolds in the NetherlandsBert Everaert, Cordula Felix, Jacques Koolen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancyH C Pitot, R M Goldberg, J M Reid, et al.Cancer Chemotherapy and Pharmacology|September 24, 2009
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumorsBhuvaneswari Ramaswamy, Tanios Bekaii-Saab, Larry J Schaaf, et al.Toxicologic Pathology|October 25, 2019
Proceedings of the 2019 National Toxicology Program Satellite SymposiumSusan A Elmore, Mark F Cesta, Torrie A Crabbs, et al.BMC Health Services Research|October 4, 2012
Exposure to second-hand smoke and direct healthcare costs in children - results from two German birth cohorts, GINIplus and LISAplusAriane Batscheider, Sylwia Zakrzewska, Joachim Heinrich, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumorsL B Saltz, D Spriggs, L J Schaaf, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 16, 2013
The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxiaMarco B E Schaaf, Dan Cojocari, Tom G Keulers, et al.Stem Cell Reports|May 24, 2016
Human Engineered Heart Tissue: Analysis of Contractile ForceIngra Mannhardt, Kaja Breckwoldt, David Letuffe-Brenière, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 15, 2018
Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomographyRobin P Kraak, Alexandre H Kajita, Hector M Garcia-Garcia, et al.Pageof 298